StrategyDrugmakers Master Rolling Out Their Own Generics To Stifle Competition
Critics say authorized generics hurt long-term competition and often perversely increase costs, even in the short term.
Generic Drug Maker Heritage Pharmaceuticals Admits to Price Fixing
The Eatontown, New Jersey-based company will pay $7.1 million to resolve criminal and civil allegations, and will cooperate with an...
InnovationCivica Rx Opens New HQ in Utah
Lehi, Utah, referred to as 'Silicon Slopes,' was chosen because it is centrally located amid Utah's universities and has become...
Trump Administration Salutes Parade of Generic Drug Approvals, but Hundreds Aren't for Sale
The FDA has approved more than 1,600 generic drug applications since January 2017 ? about a third more than it...
StrategyPhRMA, AHA Trade Blame, Barbs on High Drug Prices
Drug makers launch PR campaign blaming higher drug costs on hospital markups. Hospitals call the claims 'a brazen misrepresentation of...
InnovationHospitals Launch Not-for-Profit Civica Rx in 'Direct Challenge to Generic Drug Companies'
The project has identified 14 hospital-administered generic drugs as its initial focus to stabilize the chronically short supply and lower...
InnovationFDA Launches Streamlined Generic Drug Approval Process
The Competitive Generic Therapy designation looks to encourage the development of alternatives for drugs with inadequate generic competition.
StrategyThe yelping of the American doctor
Clinical CareGoing generic OK for clopidogrel